High Performance Liquid Chromatography Global Market Report 2024

The high performance liquid chromatography market size has grown strongly in recent years. It will grow from $4.61 billion in 2023 to $4.91 billion in 2024 at a compound annual growth rate (CAGR) of 6.6%. The growth observed during the historical period can be attributed to factors such as an upsurge in demand from the pharmaceutical industry, increasing needs within the pharmaceutical sector, requirements for food safety and quality control, a focus on environmental monitoring and compliance with regulations, and the implementation of automation and workflow optimization practices.

The high performance liquid chromatography market size is expected to see strong growth in the next few years. It will grow to $6.28 billion in 2028 at a compound annual growth rate (CAGR) of 6.4%. The anticipated growth in the forecast period can be attributed to increasing applications in biotechnology and life sciences, a growing emphasis on food safety and analysis, the integration of automation in laboratories, demand from Contract Research Organizations (CROs) and analytical labs, and a heightened focus on compliance and standardization. Key trends expected in the forecast period include a rise in biotechnology applications, an increased focus on food safety and analysis, environmental monitoring and analysis, a shift towards automated and integrated systems, and a rising demand for analytical services.

The high prevalence of chronic diseases is expected to drive the growth of the high-performance liquid chromatography (HPLC) market. Chronic diseases, including cancer, heart disease, stroke, diabetes, and arthritis, often require prolonged medical attention. HPLC plays a crucial role in analyzing medications to verify their identity, provide quantitative data, and monitor the progress of illness therapy. The Chronic Disease Burden Report 2021 highlighted that annually over 659,000 Americans succumb to heart disease, accounting for approximately one-quarter of all deaths. Additionally, cancer, the second leading cause of death in the United States, sees around 1.6 million diagnoses and 600,000 deaths each year. The rising prevalence of chronic diseases is a significant factor propelling the growth of the HPLC market.

The growth of the pharmaceutical sector is expected to be a driving force for the high-performance liquid chromatography (HPLC) market. The pharmaceutical industry, dedicated to the research, development, manufacturing, and commercialization of drugs, relies on HPLC for quality control during the drug manufacturing process. HPLC is essential for ensuring the purity, identity, and potency of pharmaceutical compounds, meeting regulatory standards before entering the market. The 2021-2030 National Health Expenditure (NHE) report forecasts an average annual increase of 5.1% in national health spending, reaching nearly $6.8 trillion by 2030. The pharmaceutical sector's growth, reflected in increased health spending, contributes to the expanding HPLC market.

Technological advancements are a prominent trend in the high-performance liquid chromatography market. Major companies are developing advanced HPLC technologies, including integrated capabilities and dual-injection systems, to enhance the technique's utility for various research applications. For example, Waters Corporation introduced the Alliance iS, an intelligent HPLC system with proactive error detection features, reducing common errors by up to 40%. Paired with Empower Chromatography Software and eConnect HPLC Columns, this system streamlines precise measurements, benefiting Quality Control (QC) laboratories and ensuring compliance with quality and safety standards.

Major companies in the HPLC market focus on product developments and launches, such as cutting-edge ultra-high-performance liquid chromatographs (UHPLCs), to maintain their market position. In February 2022, Shimadzu Corporation unveiled the Nexera XS inert, a cutting-edge UHPLC designed for biopharmaceutical analysis. This system addresses challenges such as molecule adsorption and corrosion, ensuring minimal interaction with biopolymers, reduced sample loss, and precise results. Shimadzu's innovation enhances sensitivity and data quality, marking a significant advancement in biopharmaceutical research.

In December 2021, Calibre Scientific, Inc. acquired Benson Polymeric, a polymer-based company operating in the high-performance liquid chromatography market. This acquisition allows Benson Polymeric to enhance its product offering by leveraging Calibre Scientific's extensive chromatography product portfolio.

Major companies operating in the high performance liquid chromatography market report are Waters Corporation, Thermo Fisher Scientific Inc., Agilent Technologies Inc., Shimadzu Corporation, PerkinElmer Inc., Bio-Rad Laboratories Inc., Gilson LLC, Danaher Corporation, Sartorius AG, Tosoh Bioscience GmbH, JASCO Inc., IDEX Health & Science LLC, Bruker Corporation, Orochem Technologies Inc., Merck KGaA, Restek Corporation, Knauer GmbH, GL Sciences Inc., Hitachi High-Tech Corporation, Cecil Instruments Limited, SCION Instruments, YMC Co. Ltd., KNAUER Wissenschaftliche Geräte GmbH, Valco Instruments Co. Inc., Spark Holland B.V., Teledyne Tekmar, Xylem Inc., Analytik Jena AG, Imtakt Corporation, Chromsystems Instruments & Chemicals GmbH, Advion Inc.

North America was the largest region in the high performance liquid chromatography market analysis in 2023. Asia-Pacific is expected to be the fastest-growing region in the high performance liquid chromatography market during the forecast period. The regions covered in the high performance liquid chromatography market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the high performance liquid chromatography market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The primary products associated with high-performance liquid chromatography include instruments, consumables, accessories, and software. High-performance liquid chromatography instrumentation comprises nine fundamental components, featuring data collection, an output system, and connective tubing and fittings. These tools find applications across various sectors such as clinical research, diagnostics, forensics, and others. They are utilized by diverse end users, including pharmaceutical and biotechnology companies, academic and research institutes, food and beverage companies, hospitals and clinics, environmental agencies, and other entities.

The high-performance liquid chromatography market research report is one of a series of new reports that provides high-performance liquid chromatography market statistics, including high-performance liquid chromatography industry global market size, regional shares, competitors with a high-performance liquid chromatography market share, detailed high-performance liquid chromatography market segments, market trends and opportunities, and any further data you may need to thrive in the high-performance liquid chromatography industry. This high-performance liquid chromatography market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.